Testing effectiveness (Phase 2)Study completedNCT01262976
What this trial is testing
Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults
Who this might be right for
Tuberculosis
GlaxoSmithKline 240